Replies to post #203544 on Biotech Values

[jbog]

Enta I’ll do a new one from scratch after the phase-3 data for ABT-493/ABT-530 are released

We'll have to see a couple of quarters seeing the Abbvie Sales to see what stranglehold Gilead has on the providers before anything meaningful can be determined.